EDSA - Edesa Biotech GAAP EPS of -$0.10 beats by $0.07 August, 09 2023 05:35 PM Edesa Biotech Inc. 2023-08-09 17:35:56 ET Edesa Biotech press release ( NASDAQ: EDSA ): Q3 GAAP EPS of -$0.10 beats by $0.07 . At June 30, 2023, Edesa had cash and cash equivalents of $6.46 million and working capital of $5.39 million. For further details see: Edesa Biotech GAAP EPS of -$0.10 beats by $0.07